15
Effects of Moringa Oleifera on Anti-Cancer Activity of Oncolytic Vesicular Stomatitis Virus (VSV) in Cervical Cancer Cells. HONORS THESIS BY STEPHANIE IBARRA

Effects of Moringa Oleifera on Anti-Cancer Activity. Defense Presentation

Embed Size (px)

Citation preview

Page 1: Effects of Moringa Oleifera on Anti-Cancer Activity. Defense Presentation

Effects of Moringa Oleifera on Anti-Cancer Activity of Oncolytic Vesicular Stomatitis Virus (VSV)

in Cervical Cancer Cells. HONORS THESIS

BY STEPHANIE IBARRA

Page 2: Effects of Moringa Oleifera on Anti-Cancer Activity. Defense Presentation

Outline

• Background Information

• Purpose

• Approach

• Data

• Conclusion

Page 3: Effects of Moringa Oleifera on Anti-Cancer Activity. Defense Presentation

Background Information

• Cancer – treatment, but no cure

• Intracellular/epigenetic alterations• Type I IFN Response

• Cervical cancer

• Human Papillomavirus (HPV-16, -18)

• Hysterectomy, chemotherapy, and radiation.

Page 4: Effects of Moringa Oleifera on Anti-Cancer Activity. Defense Presentation

Background Information

• Oncolytic Virotherapy (OV)

• Anticancer viruses• Oncolytic Viruses/Agents

• Natural tropism for tumor cells• Cancer epigenetic changes

Page 5: Effects of Moringa Oleifera on Anti-Cancer Activity. Defense Presentation

Background Information

• Oncolytic Viruses

• Target and kill cancer cells

• No harm to normal cells

• Control molecular cell machinery

• Two major classes

• Natural tropism for cancer cells and nonpathogenic to humans.

• Genetically manipulated vectors

Page 6: Effects of Moringa Oleifera on Anti-Cancer Activity. Defense Presentation

Background Information

• Vesicular Stomatitis Virus (VSV)

• Low pathogenicity to humans

• 11Kb with 5 coding genes

• Matrix (M) protein

• Defective Type I IFN response

• rwt vs. rM51R-M strains

Page 7: Effects of Moringa Oleifera on Anti-Cancer Activity. Defense Presentation

Background Information

• Moringa Oleifera (Moringa pterygosperma)

• Antitumor activity • Pro-apoptotic

• Anti-proliferative

• Low toxicity/safe on humans

Page 8: Effects of Moringa Oleifera on Anti-Cancer Activity. Defense Presentation

Purpose

• The goal of this project is to test the effects of methanolic (MeOH) moringa oleifera extract and vesicular stomatitis viruses (VSV), both wild type (rwt) and mutated (rM51R-M), on three different cervical cancer cell lines (SiHa, HeLa, and C4-II) upon incubation after treatment and infection.

Page 9: Effects of Moringa Oleifera on Anti-Cancer Activity. Defense Presentation

Approach

• Cervical carcinoma cell lines HeLa, SiHa, and C4-II

• VSV-GFP rwt and rM51R-M

Flow Cytometry ELISA

Page 10: Effects of Moringa Oleifera on Anti-Cancer Activity. Defense Presentation

Data – Flow Cytometry

0

10

20

30

40

50

60

70

80

% G

ATE

D

HeLa + MeOH

Figure 1. The percentage of positive gated cells (infected cells) was similar

between rwt and M51R-M, with a relative small increase of infection with

increasing MeOH moringa extract in M51R-M HeLa cells.

0

20

40

60

80

100

120

MEA

N F

LUO

RES

CEN

CE

HeLa + MeOH

Figure 2. Concentration of virion production increased with increasing amounts

of MeOH moringa extract. Increased amounts of expressed GFP were present in

HeLa cells infected with M51R-M.

Page 11: Effects of Moringa Oleifera on Anti-Cancer Activity. Defense Presentation

0

10

20

30

40

50

60

70

80

90

100

% G

ATE

D

SiHa + MeOH

Figure 3. The percentage of positive gated SiHa cells infected with rwt was high

regardless the addition of MeOH moringa extract. The percentage of infection of

SiHa cells with rM51R-M did increase upon addition of MeOH moringa extract

in comparison to the untreated sample.

0

20

40

60

80

100

120

140

160

180

200

MEA

N F

LUO

RES

CEN

CE

SiHa + MeOH

Figure 4. Concentration of viral progeny production increased with increasing

amounts of MeOH moringa extract for both rwt and rM51R-M infected cells.

Data – Flow Cytometry

Page 12: Effects of Moringa Oleifera on Anti-Cancer Activity. Defense Presentation

Data – Flow Cytometry

Figure 5. Percentage of infected cells upon infection by both VSV strains rwt and

rM51R-M. Both viral samples achieved a linear infection with of cells with

increasing concentrations of MeOH moringa extract treatment.

0

20

40

60

80

100

120

MEA

N A

BSO

RB

AN

CE

C4-II + MeOH

Figure 6. Mean production of viral progeny was observed to increase with

increasing concentrations of MeOH moringa extract in both rwt and rM51R

samples. The samples infected with rM51R-M achieved a higher progeny

production than the rwt samples.

0

10

20

30

40

50

60

70

% G

ATE

D

C4-II + MeOH

Page 13: Effects of Moringa Oleifera on Anti-Cancer Activity. Defense Presentation

Data – ELISA

0

20

40

60

80

100

120

140

MEA

N C

ON

CEN

TRA

TIO

N (

PG

/ML)

Human IL-6 - 1:1 Dilution

Figure 8. The concentration of IL-production was notoriously higher for the samples

infected with rM51R and treated with MeOH moringa extract. The rwt samples had a

similar production of IL-6 to that of the mock and thus were not affected upon

treatment.

Page 14: Effects of Moringa Oleifera on Anti-Cancer Activity. Defense Presentation

Conclusion

Analysis of the effects of Moringa oleiferamethanolic extract on anti-cancer activity upon infection with VSV oncolytic virus in cervical cancer cells showed that treatment does not hinder the degree of viral replication in cells and can potentially promote oncolytic virotherapy

Page 15: Effects of Moringa Oleifera on Anti-Cancer Activity. Defense Presentation

Thank You!